Erectile dysfunction medication induced-changes in plasma levels of homocysteine and antioxidant enzyme activities as risk factors for cardiovascular disease

Journal of Taibah University Medical Sciences

Volumn 8, Issue 3, 2013, Pages 151-156

  Baghdadi, H H ^a   Allam, A ^a   Sheweita, S A ^b  

^a TAIBAH UNIVERSITY   (Saudi Arabia)

^b ALEXANDRIA UNIVERSITY   (Egypt)

Author keywords

Catalase; Hyperhomocysteinaemia; Sildenafil citrate; Superoxide dismutase; Tadalafil; Vardenafil

Indexed keywords

ANTIOXIDANT; CATALASE; HIGH DENSITY LIPOPROTEIN; HOMOCYSTEINE; LOW DENSITY LIPOPROTEIN; SILDENAFIL; SUPEROXIDE DISMUTASE; TADALAFIL; TRIACYLGLYCEROL; VARDENAFIL;

AMINO ACID BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARDIOVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; ERECTILE DYSFUNCTION; LIPID ANALYSIS; LIPOPROTEIN BLOOD LEVEL; MALE; NONHUMAN; RAT; RISK FACTOR; TREATMENT DURATION; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 84890457770     PISSN: 16583612     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jtumed.2013.04.003     Document Type: Article

References (53)

1. M. Boolell, M.J. Allen, and S.A. Ballard Sildenafil: an orally active type 5 cyclic GMP-specific phosphodiesterase inhibitor for the treatment of penile erectile dysfunction Int J Impot Res 8 1996 47 52
2. H. Porst, R. Rosen, and H. Padma-Nathan The efficacy and tolerability of vardenafil, a new, oral, selective phosphodiesterase type 5 inhibitor, in patients with erectile dysfunction: the first at-home clinical trial Int J Impot Res 13 2001 192 199
3. T.M. Attinà, I.D. Drummond, L.S. Malatino, S.R. Maxwell, and D.J. Webb Phosphodiesterase type 5 inhibition improves arterial stiffness after exercise but not exercise capacity in hypertensive men Am J Hypertens 26 3 2013 342 350
4. H. Senzaki, C.J. Smith, and G.J. Juang Cardiac phosphodiesterase 5 (cGMP specific) modulates beta-adrenergic signaling in vivo and is down-regulated in heart failure FASEB J 15 2001 1718 1726
5. A. Das, L. Xi, and R.C. Kukreja Phosphodiesterase-5 inhibitor, sildenafil preconditions adult cardiac myocytes against necrosis and apoptosis: essential role of NO signaling J Biol Chem 280 2005 12944 12955
6. D.A. Kass Cardiac role of cyclic-GMP hydrolyzing phosphodiesterase type 5: from experimental models to clinical trials Curr Heart Fail Rep 9 3 2012 192 199
7. J.Y. Jeremy, S.A. Ballard, A.M. Naylor, M.A. Miller, and G.D. Angelini Effects of sildenafil, a type-5 cGMP phosphodiesterase inhibitor, and papaverine on cyclic GMP and cyclic AMP levels in the rabbit corpus cavernosum in vitro Br J Urol 79 1997 958 963
8. R.C. Rosen, and J.B. Kostis Overview of phosphodiesterase 5 inhibition in erectile dysfunction Am J Cardiol 92 2003 9M 18M
9. S. Uckert, and M.A. Kuczyk Cyclic nucleotide metabolism including nitric oxide and phosphodiesterase-related targets in the lower urinary tract Handb Exp Pharmacol 202 2011 527 542
10. I. Saenz de Tejada, J. Angulo, and P. Cuevas The phosphodiesterase inhibitory selectivity and the in vitro and in vivo potency of the new PDE-5 inhibitor vardenafil Int J Impot Res 13 2001 282 290
11. M. Roustit, S. Blaise, Y. Allanore, P.H. Carpentier, E. Caglayan, and J.L. Cracowski Phosphodiesterase-5 inhibitors for the treatment of secondary Raynaud's phenomenon: systematic review and meta-analysis of randomised trials Ann Rheum Dis 2013 [Epub ahead of print]
12. I. Eardley, and J. Cartledge Tadalafil (Cialis) for men with erectile dysfunction Int J Clin Pract 56 2002 300 304
13. S. Koka, A. Das, F.N. Salloum, and R.C. Kukreja Phosphodiesterase-5 inhibitor, tadalafil, attenuates oxidative stress and protects against myocardial ischemia/reperfusion injury in type 2 diabetic mice Free Radic Biol Med 2013 [Epub ahead of print]
14. M.A. Ajabnoor, M.N. Al-Ama, Z. Banjar, A.A. Rafee, and S.A. Sheweita Homocysteine level and other biochemical parameters in cardiovascular disease patients with diabetes mellitus Med Sci Monit 12 2003 523 527
15. Z. Paknahad, A. Chitsaz, A.H. Zadeh, and E. Sheklabadi Effects of common anti-epileptic drugs on the serum levels of homocysteine and folic acid Int J Prev Med Suppl. 1 2012 S186 S190
16. S. Bhargava, A. Ali, A. Manocha, M. Kankra, S. Das, and L.M. Srivastava Homocysteine in occlusive vascular disease: a risk marker or risk factor Indian J Biochem Biop 49 6 2012 414 420
17. H.W. Nah, and J.S. Kim Premature intracranial arterial calcification in a patient with hyperhomocysteinemia Neurology 75 24 2010 2252 2259
18. D.E.L. Wilcken, and B. Wilcken The pathogenesis of coronary artery disease. A possible role for methionine metabolism J Clin Invest 57 1976 1079 1082
19. H. Refsum, P.M. Ueland, O. Nygard, and S.E. Vollset Homocysteine and cardiovascular disease Annu Rev Med 49 1998 31 62
20. T. Huang, G. Yuan, Z. Zhang, Z. Zou, and D. Li Cardiovascular pathogenesis in hyperhomocysteinemia Asia Pac J Clin Nutr 17 1 2008 8 16
21. C.J. Boushey, S.A.A. Beresford, G.S. Omenn, and A.G. Motulsky A quantitative assessment of plasma homocysteine as a risk factor for vascular disease - probable benefits of increasing folic acid intakes J Am Med Assoc 274 1995 1049 1057
22. I.M. Graham, L.E. Daly, and H.M. Refsum Plasma homocysteine as a risk factor for vascular disease - the European concerted action project J Am Med Assoc 277 1997 1775 1781
23. M.S. Morris, M. Fava, P.F. Jacques, J. Selhub, and I.H. Rosenberg Depression and folate status in the US population Psychother Psychosom 72 2 2003 80 88
24. C.J. Bates, J. Schneede, G. Mishra, A. Prentice, and M.A. Mansoor Relationship between methylmalonic acid, homocysteine, vitamin B(12) intake and status and socio-economic indices, in a subset of participants in the. British National Diet and Nutrition Survey of people aged 65 y and over Eur J Clin Nutr 57 2 2003 349 357
25. K.S. McCully, and R.B. Wilson Homocysteine theory of arteiosclerosis Atherosclerosis 22 1975 215 227
26. J.C. Tasi, M.A. Perrella, and M. Yoshizumi Promotion of vascular smooth muscle cell growth by homocysteine: a link to atherosclerosis Proc Natl Acad Sci U S A 91 1994 6369 6373
27. K.S. Wu, P. Chook, and Y.I. Lolin Hyperhomocyst(e)inemia is a risk factor for arterial endothelial dysfunction in humans Circulation 96 1997 2542 2544
28. H. Yokote, A. Shiraishi, S. Shintani, and T. Shiigai Acute multiple brain infarction in large-artery atherosclerosis is associated with hyperhomocyst(e)inemia Acta Neurol Scand 116 4 2007 243 247
29. S.A. Sheweita, A.M. Tilmisany, and H. Al-Sawaf Mechanisms of male infertility: role of antioxidants Curr Drug Metab 6 5 2005 495 501
30. A. Zabłocka, and M. Janusz The two faces of reactive oxygen species Postepy Hig Med Dosw 62 2008 118 124
31. J.H. Kim, H. Kim, Y.H. Kim, W.S. Chung, J.K. Suh, and S.J. Kim Antioxidant effect of captopril and enalapril on reactive oxygen species-induced endothelial dysfunction in the rabbit abdominal aorta Korean J Thorac Cardiovasc Surg 46 1 2013 14 21
32. W. Deng, T.J. Bivalacqua, H.C. Champion, W.J. Hellstrom, S.N. Murthy, and P.J. Kadowitz Superoxide dismutase - a target for gene therapeutic approach to reduce oxidative stress in erectile dysfunction Methods Mol Biol 610 2010 213 227
33. F. Frantzen, A.L. Faaren, I. Alfheim, and A.K. Nordhei An enzyme conversion immunoassay for determining total homocysteine in plasma or serum Clin Chem 44 1998 311 316
34. R.F. Beers, and I.W. Sizer A spectrophotometric method for measuring the breakdown of hydrogen peroxide by catalase J Biol Chem 195 1 1952 133 140
35. M.F. Bellamy, and I.F.W. McDowell Putative mechanisms for vascular damage by homocysteine J Inherit Metab Dis 20 1997 307 315
36. K.S. Woo, P. Chook, and Y.I. Lolin Hyperhomocyst(e)inemia is a risk factor for arterial endothelial dysfunction in humans Circulation 96 8 1997 2542 2554
37. L.H. Liu, Z. Guo, M. Feng, Z.Z. Wu, Z.M. He, and Y. Xiong Protection of DDAH2 overexpression against homocysteine-induced impairments of DDAH/ADMA/NOS/NO pathway in endothelial cells Cell Physiol Biochem 30 6 2012 1413 1422
38. L.A. Harker, R. Ross, S.J. Slichter, and C.R. Scott Homocystine-induced arteriosclerosis. The role of endothelial cell injury and platelet response in its genesis J Clin Invest 58 3 1976 731 741
39. G. Blundell, B.G. Jones, F.A. Rose, and N. Tudball Homocysteine mediated endothelial cell toxicity and its amelioration Atherosclerosis 122 2 1996 163 172
40. R.T. Wall, J.M. Harlan, L.A. Harker, and G.E. Striker Homocysteine-induced endothelial cell injury in vitro: a model for the study of vascular injury Thromb Res 18 1-2 1980 113 121
41. J. Malinowska, M. Tomczynska, and B. Olas Changes of blood platelet adhesion to collagen and fibrinogen induced by homocysteine and its thiolactone Clin Biochem 45 15 2012 1225 1228
42. T. Jer-Chia, M.A. Perrella, and M. Yoshizumi Promotion of vascular smooth muscle cell growth by homocysteine: a link to atherosclerosis Proc Natl Acad Sci U S A 91 1994 6369 6373
43. B. Zhang, L. Qiu, M. Fu, and S. Hu Interference in mevalonate pathway ameliorates homocysteine-induced endothelium-dysfunction Eur J Pharmacol 692 1-3 2012 61 68
44. M. El-Far, Ael-G El-Motwally, I.A. Hashem, and N. Bakry Biochemical role of intravaginal sildenafil citrate as a novel antiabortive agent in unexplained recurrent spontaneous miscarriage: first clinical study of four case reports from Egypt Clin Chem Lab Med 47 11 2009 1433 1438
45. S.A. Sheweita, and B.Y. Sheikh Can dietary antioxidants reduce the incidence of brain tumors? Curr Drug Metab 12 6 2011 587 593
46. Q. Zhang, Z.M. Radisavljevic, M.B. Siroky, and K.M. Azadzoi Dietary antioxidants improve arteriogenic erectile dysfunction Int J Androl 34 3 2011 225 235
47. M. Pravenec, V. Kozich, and J. Krijt Folate deficiency is associated with oxidative stress, increased blood pressure, and insulin resistance in spontaneously hypertensive rats Am J Hypertens 26 1 2013 135 140
48. M. Hotston, J.Y. Jeremy, and J. Bloor Homocysteine and copper interact to promote type 5 phosphodiesterase expression in rabbit cavernosal smooth muscle cells Asian J Androl 10 6 2008 905 913
49. 2 generation by rat heart mitochondria Mol Cell Biochem 309 1-2 2008 77 85
50. T. Omae, T. Nagaoka, I. Tanano, and A. Yoshida Homocysteine inhibition of endothelium-dependent nitric oxide-mediated dilation of porcine retinal arterioles via enhanced superoxide production Invest Ophthalmol Vis Sci 2013 [Epub ahead of print]
51. Y. Ohara, T.E. Peterson, and D.G. Harrison Hypercholesterolemia increases endothelial superoxide anion production J Clin Invest 91 6 1993 2546 2551
52. J.H. Suh, C. Romain, and R. González-Barrio Raspberry juice consumption, oxidative stress and reduction of atherosclerosis risk factors in hypercholesterolemic golden Syrian hamsters Food Funct 2 7 2011 400 405
53. A. Santi, M.M. Duarte, C.C. de Menezes, and V.L. Loro Association of lipids with oxidative stress biomarkers in subclinical hypothyroidism Int J Endocrinol 8 2012 559 563